Kaleido Biosciences (KLDO) Short Interest Ratio & Short Volume

Short interest is the volume of Kaleido Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,400,000 shares of KLDO short. 7.30% of Kaleido Biosciences' shares are currently sold short. Learn More on Kaleido Biosciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.30% of Kaleido Biosciences' floating shares are currently sold short.

Kaleido Biosciences saw a drop in short interest in April. As of April 15th, there was short interest totaling 1,400,000 shares, a drop of 40.2% from the previous total of 2,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Kaleido Biosciences currently has issued a total of 42,623,000 shares. Some of Kaleido Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kaleido Biosciences currently has a public float of 19,190,000 shares.

7.30% of Kaleido Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Kaleido Biosciences: CASI Pharmaceuticals, Inc. (0.99%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.77 billion), Charter Communications, Inc. ($4.21 billion), HP Inc. ($2.60 billion), Lucid Group, Inc. ($2.33 billion), GameStop Corp. ($2.13 billion), Rivian Automotive, Inc. ($2.10 billion), Wayfair Inc. ($1.96 billion), Carnival Co. & plc ($1.81 billion), Teladoc Health, Inc. ($1.66 billion), and Plug Power Inc. ($1.63 billion). View all of the most shorted stocks.

Short selling KLDO is an investing strategy that aims to generate trading profit from Kaleido Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Kaleido Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KLDO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KLDO, twice per month. The most recent reporting period available is April, 15 2022.